LAURA TURER: Open Payments
NPI 1790144970 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 20 payments from 10 companies in 2025. Trend: 2023 $95 · 2024 $757 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $241 |
| BTG International Inc. | 1 | $99 |
| Karyopharm Therapeutics Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Adaptive Biotechnologies Corporation | 1 | $32 |
| Tempus AI, Inc | 2 | $30 |
| BeOne Medicines USA, Inc. | 1 | $29 |
| Celgene Corporation | 1 | $22 |
| Legend Biotech USA Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $16 |
Products named: CARVYKTI, VORAXAZE, TECVAYLI, XPOVIO, NINLARO, clonoSEQ, XT CDX, TALVEY.
Industry payments across TX — which companies pay providers there.
